A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Vaccine

• Publication date

  2011-08-26

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.vaccine.2011.06.084PMID 21723899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heat-Stable Enterotoxin of Enterotoxigenic Escherichia coli as a Vaccine Target

  2010cited by this paper
• The Longus type IV pilus of enterotoxigenic Escherichia coli (ETEC) mediates bacterial self-aggregation and protection from antimicrobial agents.

  2010cited by this paper
• Molecular mechanisms of enterotoxigenic Escherichia coli infection.

  2010cited by this paper
• Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network.

  2010cited by this paper
• Longus, a Type IV Pilus of Enterotoxigenic Escherichia coli, Is Involved in Adherence to Intestinal Epithelial Cells

  2010cited by this paper
• A decade of the Asian Rotavirus Surveillance Network: achievements and future directions.

  2009cited by this paper
• Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data.

  2009cited by this paper
• Children with the Le(a+b−) Blood Group Have Increased Susceptibility to Diarrhea Caused by Enterotoxigenic Escherichia coli Expressing Colonization Factor I Group Fimbriae

  2009cited by this paper
• Phenotypic and Genotypic Analysis of Enterotoxigenic Escherichia coli in Samples Obtained from Egyptian Children Presenting to Referral Hospitals

  2008cited by this paper
• Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells

  2008cited by this paper
• Case Series Study of Traveler's Diarrhea in U.S. Military Personnel at Incirlik Air Base, Turkey

  2008cited by this paper
• Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

  2008cited by this paper
• Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh.

  2008cited by this paper
• Acute gastrointestinal infection, respiratory illness, and noncombat injury among US military personnel during Operation Bright Star 2005, in Northern Egypt.

  2007cited by this paper
• Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization

  2007cited by this paper
• Comparison of enterotoxigenic Escherichia coli isolated from surface water and diarrhoeal stool samples in Bangladesh.

  2007cited by this paper
• Mucosal and Systemic Immune Responses in Patients with Diarrhea Due to CS6-Expressing Enterotoxigenic Escherichia coli

  2007cited by this paper
• Comparative Analyses of Phenotypic and Genotypic Methods for Detection of Enterotoxigenic Escherichia coli Toxins and Colonization Factors

  2007cited by this paper
• Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

  2007cited by this paper
• Genotypic and Phenotypic Profiles of Enterotoxigenic Escherichia coli Associated with Acute Diarrhea in Tunis, Tunisia

  2007cited by this paper
• Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984–2005

  2007cited by this paper
• Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

  2007cited by this paper
• Disease Burden Due to Enterotoxigenic Escherichia coli in the First 2 Years of Life in an Urban Community in Bangladesh

  2007cited by this paper
• Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review.

  2006cited by this paper
• Clinic-based surveillance for bacterial- and rotavirus-associated diarrhea in Egyptian children.

  2006cited by this paper
• In vivo expression of the heat stable (estA) and heat labile (eltB) toxin genes of enterotoxigenic Escherichia coli (ETEC).

  2006cited by this paper
• Identification of a Two-Partner Secretion Locus of Enterotoxigenic Escherichia coli

  2006cited by this paper
• Incidence, etiology, and impact of diarrhea among deployed US military personnel in support of Operation Iraqi Freedom and Operation Enduring Freedom.

  2006cited by this paper
• Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea.

  2006cited by this paper
• Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico.

  2006cited by this paper
• Enterotoxigenic Escherichia coli colonization factor types collected from 1997 to 2001 in US military personnel during operation Bright Star in northern Egypt.

  2006cited by this paper
• Enteric pathogens associated with diarrhea in children in Fayoum, Egypt.

  2006cited by this paper
• The possession of coli surface antigen CS6 by enterotoxigenicEscherichia coli of serogroups O25, O27, O148, and O159: a possible colonization factor?

  2005cited by this paper
• Enterotoxigenic Escherichia coli and Vibrio cholerae Diarrhea, Bangladesh, 2004

  2005cited by this paper
• The occurence of colonisation factors (CFA/I,CFA/II and E8775) in enterotoxigenicEscherichia coli from various countries in South East Asia

  2005cited by this paper
• Outbreaks of cholera-like diarrhoea caused by enterotoxigenic Escherichia coli in the Brazilian Amazon Rainforest.

  2005cited by this paper
• Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention

  2005cited by this paper
• Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method.

  2004cited by this paper
• Phenotypic Profiles of Enterotoxigenic Escherichia coli Associated with Early Childhood Diarrhea in Rural Egypt

  2004cited by this paper
• Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world.

  2004cited by this paper
• Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium.

  2003cited by this paper
• Prevalence of enterotoxigenic Escherichia coli (ETEC) in hospitalized acute diarrhea patients in Denpasar, Bali, Indonesia.

  2003cited by this paper
• Type IV Longus Pilus of Enterotoxigenic Escherichia coli: Occurrence and Association with Toxin Types and Colonization Factors among Strains Isolated in Argentina

  2002cited by this paper
• Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau.

  2002cited by this paper
• Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay).

  2002cited by this paper
• Prevalence of Enterotoxigenic Escherichia coli Strains Harboring the Longus Pilus Gene in Brazil

  2002cited by this paper
• Concomitant Infection of EnterotoxigenicEscherichia coli in an Outbreak of Cholera Caused byVibrio cholerae O1 and O139 in Ahmedabad, India

  2001cited by this paper
• Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia.

  2001cited by this paper
• Identification of a Cluster of Strains Bearing a New Adhesin among Genetically Diverse Enterotoxigenic Escherichia coli Isolates of Serogroup O20

  2001cited by this paper
• Enterotoxin-Specific Immunoglobulin E Responses in Humans after Infection or Vaccination with Diarrhea-Causing Enteropathogens

  2000cited by this paper
• Identification of Enterotoxigenic Escherichia coli Harboring Longus Type IV Pilus Gene by DNA Amplification

  2000cited by this paper
• Human antibody response to longus type IV pilus and study of its prevalence among enterotoxigenic Escherichia coli in Bangladesh by using monoclonal antibodies.

  2000cited by this paper
• Prevalence of Toxin Types and Colonization Factors in Enterotoxigenic Escherichia coli Isolated during a 2-Year Period from Diarrheal Patients in Bangladesh

  2000cited by this paper
• Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997.

  2000cited by this paper
• Prospective Cohort Study of EnterotoxigenicEscherichia coli Infections in Argentinean Children

  1999cited by this paper
• Intestinal Immune Responses in Patients Infected with Enterotoxigenic Escherichia coli and in Vaccinees

  1999cited by this paper
• Norwalk-like virus and bacterial pathogens associated with cases of gastroenteritis onboard a US Navy ship.

  1999cited by this paper
• Epidemiology of enterotoxigenic Escherichia coli diarrhea in a pediatric cohort in a periurban area of lower Egypt.

  1999cited by this paper
• Characterization of an EnterotoxigenicEscherichia coli Strain from Africa Expressing a Putative Colonization Factor

  1999cited by this paper
• Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli.

  1998cited by this paper
• Aetiological, clinical and epidemiological characteristics of a seasonal peak of diarrhoea in Dhaka, Bangladesh.

  1998cited by this paper
• Epidemiology and properties of heat-stable enterotoxin-producing Escherichia coli serotype O169[ratio ]H41

  1998cited by this paper
• Virulence properties of Escherichia coli isolated from Ethiopian patients with acute or persistent diarrhoea.

  1998cited by this paper
• Clonal Nature of Enterotoxigenic Escherichia coliSerotype O6:H16 Revealed by Randomly Amplified Polymorphic DNA Analysis

  1998cited by this paper
• Analysis of incidence of infection with enterotoxigenic Escherichia coli in a prospective cohort study of infant diarrhea in Nicaragua

  1997cited by this paper
• Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli

  1997cited by this paper
• Enterotoxigenic Escherichia coli (ETEC) in hospitalised Arab infants from Judea area--west bank, Israel.

  1997cited by this paper
• Longus pilus of enterotoxigenic Escherichia coli and its relatedness to other type-4 pili--a minireview.

  1997cited by this paper
• Coli surface antigens associated with enterotoxigenic Escherichia coli strains isolated from persons with traveler's diarrhea in Asia

  1997cited by this paper
• Distribution of colonization factor antigens among enterotoxigenic Escherichia coli strains isolated from patients with diarrhea in Nepal, Indonesia, Peru, and Thailand

  1997cited by this paper
• Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt.

  1997cited by this paper
• Colonization factors of enterotoxigenic Escherichia coli isolated from children in north India.

  1996cited by this paper
• Colonization factors of human enterotoxigenic Escherichia coli (ETEC).

  1996cited by this paper
• Enterotoxigenic Escherichia coli associated diarrhoea among infants aged less than six months in Calcutta, India

  1996cited by this paper
• Rapid identification of colonization factor antigens I & II of enterotoxigenic Escherichia coli by coagglutination test.

  1995cited by this paper
• Antibody responses against Escherichia coli heat-labile toxin and colonization factor antigens I and II in Argentinian children.

  1995cited by this paper
• Colonization factors of enterotoxigenic E. coli (ETEC) from residents of northern Egypt.

  1995cited by this paper
• Colonisation factors amongst clinical isolates of enterotoxigenic Escherichia coli.

  1995cited by this paper
• A survey of enteropathogens among United States military personnel during Operation Bright Star '94, in Cairo, Egypt.

  1995cited by this paper
• Isolation of enterotoxigenic Escherichia coli from British troops in Saudi Arabia

  1995cited by this paper
• Prevalence and association of the longus pilus structural gene (lngA) with colonization factor antigens, enterotoxin types, and serotypes of enterotoxigenic Escherichia coli

  1995cited by this paper
• Use of a new oligonucleotide probe for detection of colonization factor antigen III gene in enterotoxigenicEscherichia coli

  1995cited by this paper
• Epidemiological aspects of enterotoxigenic Escherichia coli diarrhoea in infants in the Jerusalem area.

  1995cited by this paper
• Longus: a long pilus ultrastructure produced by human enterotoxigenic Escherichia coli

  1994cited by this paper
• Prevalence of Colonization Factor Antigens (CFAs) and Adherence to HeLa Cells in Enterotoxigenic Escherichia coli Isolated from Feces of Children in São Paulo

  1994cited by this paper
• Genotypic and phenotypic identification of coli surface antigen 6-positive enterotoxigenic Escherichia coli

  1994cited by this paper
• The aquatic environment as a reservoir of Vibrio cholerae: a review.

  1993cited by this paper
• A new fimbrial putative colonization factor, PCFO20, in human enterotoxigenic Escherichia coli

  1993cited by this paper
• Serotypes and colonization factors of enterotoxigenic Escherichia coli isolated in various countries

  1993cited by this paper
• Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East

  1993cited by this paper
• Presence of colonization factor antigen IV (CS5CS6) in O29:H21 enterotoxigenic Escherichia coli isolated from children with diarrhea in Brazil.

  1993cited by this paper
• Molecular characterization of enterotoxigenic Escherichia coli (ETEC) isolated in New Caledonia (value of potential protective antigens in oral vaccine candidates).

  1993cited by this paper
• Epidemiology of diarrhoeal disease: implications for control by vaccines.

  1993cited by this paper
• Loss of some virulence factors of enterotoxigenic Escherichia coli on repeated subcultures.

  1992cited by this paper
• Relationship between enterotoxigenic Escherichia coli and diarrhea among children in Buenos Aires.

  1992cited by this paper
• Enterotoxigenic and necrotizing Escherichia coli in human diarrhoea in Spain

  1992cited by this paper
• Occurrence of colonization factor antigens I & II in enterotoxigenic Escherichia coli associated diarrhoea in Iran & correlation with severity of disease.

  1992cited by this paper
• Enterotoxigenic Escherichia coli associated with infant diarrhoea in Galicia, north-western Spain.

  1991cited by this paper
• Surveys of human enterotoxigenic Escherichia coli from three different geographical areas for possible colonization factors

  1991cited by this paper
• Colonization factors of enterotoxigenic Escherichia coli isolated from children with diarrhea in Argentina

  1991cited by this paper

• Vaccine Candidates Designed to Prevent Enterotoxigenic Escherichia coli Diarrhoea: A Scoping Review of Clinical Trials Evaluating Vaccine Candidates in Development

  2026cites this paper
• Deleterious consequences of Shiga toxin in the CNS

  2026cites this paper
• Vaccine-enhanced competition permits rational bacterial strain replacement in the gut.

  2025cites this paper
• Incidence rates of resistant enterotoxigenic Escherichia coli in fresh vegetables and salads

  2025cites this paper
• MecVax, an Epitope- and Structure-Based Broadly Protective Subunit Vaccine Against Enterotoxigenic Escherichia coli (ETEC)

  2025cites this paper
• Conserved antigens for enteric vaccines

  2025cites this paper
• Immunogenicity and preclinical efficacy characterization of ShecVax, a combined vaccine against Shigella and enterotoxigenic Escherichia coli

  2025cites this paper
• Protective antibodies against enterotoxigenic Escherichia coli are generated from heat-labile toxoid vaccination and exhibit subject- and vaccine-specific diversity

  2025cites this paper
• Emergence of porcine-derived hybrid Escherichia coli with dual-disease manifestations in intestinal and extraintestinal niches

  2025cites this paper
• Enterotoxigenic Escherichia coli Vaccine Candidate MecVax With Protein Antigens Prepared From Animal‐Free Media Is Equally Immunogenic and Protective Against Adhesins CFA/I, CS1–CS6 and Toxins LT and STa

  2025cites this paper
• Recent progress in enterotoxigenic Escherichia coli vaccine research and development

  2025cites this paper
• Whole genome characterisation of Enterotoxigenic Escherichia coli circulating in Zambia

  2025cites this paper
• The colonization factor CS6 of enterotoxigenic Escherichia coli contributes to host cell invasion.

  2024cites this paper
• Epidemiology of enterotoxigenic Escherichia coli and impact on the growth of children in the first two years of life in Lima, Peru

  2024cites this paper
• Age-dependent pathogenic profiles of enterotoxigenic Escherichia coli diarrhea in Bangladesh

  2024cites this paper
• MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1–CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC)

  2024influential citation
• The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia

  2024cites this paper
• Field evaluation of a simple and rapid diagnostic test, RLDT to detect Shigella and enterotoxigenic E. coli in Indian children

  2024cites this paper
• Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers

  2024cites this paper
• Seroprevalence Study of Conserved Enterotoxigenic Escherichia coli Antigens in Globally Diverse Populations

  2023cites this paper
• Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic Escherichia coli intestinal colonization in a rabbit model

  2023cites this paper
• Polyvalent Protein Adhesin MEFA-II Induces Functional Antibodies against Enterotoxigenic Escherichia coli (ETEC) Adhesins CS7, CS12, CS14, CS17, and CS21 and Heat-Stable Toxin (STa)

  2023cites this paper
• Field evaluation of a simple and rapid diagnostic test, RLDT to detect Shigella and enterotoxigenic E. coli in Indian children

  2023cites this paper
• Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa

  2023cites this paper
• A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions

  2023cites this paper
• Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC) colonization antigens

  2023cites this paper
• Recombinant Escherichia coli BL21 with LngA Variants from ETEC E9034A Promotes Adherence to HT-29 Cells

  2023cites this paper
• Circulation of enterotoxigenic Escherichia coli (ETEC) isolates expressing CS23 from the environment to clinical settings

  2023cites this paper
• Caracterización molecular de Escherichia coli diarreogénica proveniente de población pediátrica ambulatoria con diarrea, atendida en dos hospitales de Buenos Aires, Argentina

  2023cites this paper
• A Polyvalent Adhesin–Toxoid Multiepitope-Fusion-Antigen-Induced Functional Antibodies against Five Enterotoxigenic Escherichia coli Adhesins (CS7, CS12, CS14, CS17, and CS21) but Not Enterotoxins (LT and STa)

  2023cites this paper
• Insights Into Long Non-Coding RNA and mRNA Expression in the Jejunum of Lambs Challenged With Escherichia coli F17

  2022cites this paper
• Bacterial travellers' diarrhoea: A narrative review of literature published over the past 10 years.

  2022cites this paper
• Food animals as reservoirs and potential sources of multidrug-resistant diarrheagenic E. coli pathotypes: Focus on intensive pig farming in South Africa

  2022cites this paper
• Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate

  2022cites this paper
• Evaluation of the effect of Saccharomyces cerevisiae on the expression of enterotoxin genes in Escherichia coli O157: H7 (EHEC) and Escherichia coli H10407 (ETEC).

  2022cites this paper
• Intramuscularly Administered Enterotoxigenic Escherichia coli (ETEC) Vaccine Candidate MecVax Prevented H10407 Intestinal Colonization in an Adult Rabbit Colonization Model

  2022cites this paper
• Non-Coding Transcriptome Provides Novel Insights into the Escherichia coli F17 Susceptibility of Sheep Lamb

  2022cites this paper
• Determination of extended-spectrum β-lactamase producing and hybrid pathotypes of Escherichia coli isolates from diarrheic samples

  2022cites this paper
• Controlled Human Infection Models To Accelerate Vaccine Development

  2022cites this paper
• Enterotoxigenic Escherichia coli: intestinal pathogenesis mechanisms and colonization resistance by gut microbiota

  2022cites this paper
• Evaluation of Multivalent Enterotoxigenic Escherichia coli Vaccine Candidate MecVax Antigen Dose-Dependent Effect in a Murine Model

  2022cites this paper
• Immune Response after Skin Delivery of a Recombinant Heat-Labile Enterotoxin B Subunit of Enterotoxigenic Escherichia coli in Mice

  2022cites this paper
• The Controlled Human Infection Model for Enterotoxigenic Escherichia coli.

  2021cites this paper
• Genomic Epidemiology and Antimicrobial Susceptibility Profile of Enterotoxigenic Escherichia coli From Outpatients With Diarrhea in Shenzhen, China, 2015–2020

  2021cites this paper
• Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants

  2021cites this paper
• Human Pathogenic Enterobacterales

  2021cites this paper
• The Emergence of Extended-Spectrum β-Lactamase Producing and Hybrid Pathotypes of Escherichia Coli Isolates from Diarrheic Human Cases: A New Public Health Concern in Iran

  2021cites this paper
• Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design

  2021cites this paper
• Elevated Extracellular cGMP Produced after Exposure to Enterotoxigenic <named-content content-type='genus-species'>Escherichia coli</named-content> Heat-Stable Toxin Induces Epithelial IL-33 Release and Alters Intestinal Immunity

  2021influential citation
• In Vitro and In Vivo Assessment of the Potential of Escherichia coli Phages to Treat Infections and Survive Gastric Conditions

  2021cites this paper
• Distribution of virulence factors and its relatedness towards the antimicrobial response of enterotoxigenic Escherichia coli strains isolated from patients in Kolkata, India

  2021influential citation
• Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.

  2021cites this paper
• Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access

  2021cites this paper
• Escherichia Coli Encoding Extended-Spectrum Beta-Lactamases Isolated from Diarrheic Patients in Minna, Nigeria

  2021cites this paper
• Functional analysis of colonization factor antigen I positive enterotoxigenic Escherichia coli identifies genes implicated in survival in water and host colonization

  2021cites this paper
• Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli

  2021cites this paper
• Molecular characterization of enterotoxigenic Escherichia coli toxins and colonization factors in children under five years with acute diarrhea attending Kisii Teaching and Referral Hospital, Kenya

  2021cites this paper
• An integrative docking and simulation-based approach towards the development of epitope-based vaccine against enterotoxigenic Escherichia coli

  2021cites this paper
• Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate

  2021cites this paper
• Experimental vaccination with nanoparticles containing Escherichia coli virulence factors

  2021cites this paper
• Development and Comparison of a Panel of Modified CS17 Fimbrial Tip Adhesin Proteins as Components for an Adhesin-Based Vaccine against Enterotoxigenic Escherichia coli

  2021cites this paper
• Elevated Extracellular cGMP Produced after Exposure to Enterotoxigenic Escherichia coli Heat-Stable Toxin Induces Epithelial IL-33 Release and Alters Intestinal Immunity

  2021influential citation
• Infectious Disorders of the Lower Gastrointestinal Tract

  2020cites this paper
• Oral Vaccines for Enterotoxigenic Escherichia coli

  2020cites this paper
• RELATIONSHIP BETWEEN ANTIBIOTIC RESISTANCE AND SANITIZER SUSCEPTIBILITY OF ESCHERICHIA COLI ISOLATED FROM AGRICULTURAL WATER USED IN HAWAII

  2020cites this paper
• Jejunitis and Ileitis

  2020cites this paper
• Non-Neoplastic Pathology of the Gastrointestinal Tract

  2020cites this paper
• Drug-Induced Gastrointestinal Disease

  2020cites this paper
• Inflammatory Bowel Disease and the Upper Gastrointestinal Tract

  2020cites this paper
• Establishment and Validation of Pathogenic CS17+ and CS19+ Enterotoxigenic Escherichia coli Challenge Models in the New World Primate Aotus nancymaae

  2020cites this paper
• Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model.

  2020cites this paper
• Diverticular Disease, Mucosal Prolapse, and Related Conditions

  2020cites this paper
• Duodenitis

  2020cites this paper
• Mimics of Inflammatory Bowel Disease

  2020cites this paper
• Infections of the Oesophagus and Rare Forms of Oesophagitis

  2020cites this paper
• Evaluation of the immunogenicity and protective efficacy of an ETEC CFA/I adhesin-heat-labile 1 toxin chimera.

  2020cites this paper
• Heat‐stable enterotoxin inhibits intestinal stem cell expansion to disrupt the intestinal integrity by downregulating the Wnt/β‐catenin pathway

  2020cites this paper
• Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial

  2020cites this paper
• Cross-Reactivity, Epitope Mapping, and Potency of Monoclonal Antibodies to Class 5 Fimbrial Tip Adhesins of Enterotoxigenic <named-content content-type='genus-species'>Escherichia coli</named-content>

  2020cites this paper
• Types of Gastritis

  2020cites this paper
• Non-Neoplastic Diseases of the Anal Canal

  2020cites this paper
• A Review of Enterotoxigenic Escherichia coli Infection in Piglets: Public Health Importance

  2020cites this paper
• Histology of Gastroesophageal Reflux Disease and Barrett’s Oesophagus

  2020cites this paper
• Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments

  2020cites this paper
• Investigation of a monoclonal antibody against enterotoxigenic 1 Escherichia coli , expressed as secretory IgA1 and IgA2 in plants. 2

  2020cites this paper
• Index

  2020cites this paper
• Coeliac Disease

  2020cites this paper
• Pathogenicity Factors of Genomic Islands in Intestinal and Extraintestinal Escherichia coli

  2020cites this paper
• Preface

  2020cites this paper
• Clinical aspects of heat-labile and heat-stable toxin-producing enterotoxigenic Escherichia coli: a prospective study among Finnish travellers.

  2020cites this paper
• Gastrointestinal Ischemia and Vascular Disorders

  2020cites this paper
• Normal Oesophageal, Gastric and Duodenal Mucosa

  2020cites this paper
• Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin–Heat-Labile Toxin Chimera

  2020cites this paper
• Epidemiology of Enterotoxigenic Escherichia coli infection in Minnesota, 2016–2017

  2020cites this paper
• Oral administration of a single anti-CfaE nanobody provides broadly cross-protective immunity against major pathogenic Enterotoxigenic Escherichia coli strains

  2020cites this paper
• Assessment of Gastric Biopsies

  2020cites this paper
• Paediatric Conditions

  2020cites this paper
• Transplantation, Immunodeficiency, and Immunosuppression

  2020cites this paper
• Normal Lower Gastrointestinal Mucosa

  2020cites this paper
• Microscopic Colitis

  2020cites this paper